Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (831-840 of 1,066) with videos related to

Pageof 107
Sort By:
Blood|June 21, 2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplicationSusan P Whitman, Björn Hackanson, Sandya Liyanarachchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2007
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesisRene Opavsky, Shih-Yin Tsai, Martin Guimond, et al.
Dalton Transactions (Cambridge, England : 2003)|October 18, 2022
Curcumin-based ionic Pt(II) complexes: antioxidant and antimicrobial activityRossella Caligiuri, Giuseppe Di Maio, Nicolas Godbert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVLucia Mazzacurati, Marco Marzulli, Bonnie Reinhart, et al.
Cell Reports|July 5, 2016
NKp80 Defines a Critical Step during Human Natural Killer Cell DevelopmentAharon G Freud, Karen A Keller, Steven D Scoville, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variantWenjuan Dong, Jing Wang, Lei Tian, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agentsLaurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Leukemia|September 27, 2013
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myelomaJ Chu, Y Deng, D M Benson, et al.
ACS Nano|June 20, 2020
Biodegradable and Insoluble Cellulose Photonic Crystals and MetasurfacesVincenzo Caligiuri, Giacomo Tedeschi, Milan Palei, et al.
Blood|June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cellsFrancois Romagné, Pascale André, Pieter Spee, et al.
Pageof 107

Showing results (831-840 of 1,066) with videos related to

Sort By:
Pageof 107
Blood|June 21, 2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplicationSusan P Whitman, Björn Hackanson, Sandya Liyanarachchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2007
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesisRene Opavsky, Shih-Yin Tsai, Martin Guimond, et al.
Dalton Transactions (Cambridge, England : 2003)|October 18, 2022
Curcumin-based ionic Pt(II) complexes: antioxidant and antimicrobial activityRossella Caligiuri, Giuseppe Di Maio, Nicolas Godbert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVLucia Mazzacurati, Marco Marzulli, Bonnie Reinhart, et al.
Cell Reports|July 5, 2016
NKp80 Defines a Critical Step during Human Natural Killer Cell DevelopmentAharon G Freud, Karen A Keller, Steven D Scoville, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variantWenjuan Dong, Jing Wang, Lei Tian, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agentsLaurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Leukemia|September 27, 2013
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myelomaJ Chu, Y Deng, D M Benson, et al.
ACS Nano|June 20, 2020
Biodegradable and Insoluble Cellulose Photonic Crystals and MetasurfacesVincenzo Caligiuri, Giacomo Tedeschi, Milan Palei, et al.
Blood|June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cellsFrancois Romagné, Pascale André, Pieter Spee, et al.
Pageof 107